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CHAPTER TEN

Division of Hematology
ALLAN

J.

ERSLEV,

M.D.

"The blood is the life.))
-DEUTERONOMY 12:23

early part of this century medicine
began to change from an art to a science,
from observation and palliation to testing and
treatment. This change was associated with an
increasing demand for doctors to be informed and
experienced in the management of all illnesses,
and it becanle more and more difficult to live up
to the Oslcrian tradition of being a complete
general physician. The field was too great; many
physicians began to restrict their study to certain
diseases and became recognized not for their
breadth of knowledge but rather for their narrow
competence in the malfunction of a single organ.
At Jefferson, John Chalmers DaCosta, Jr., a cousin
of John Chalmers DaCosta, the Gross Professor of
Surgery, was the first American physician to write
a textbook on hematology (Figure ro-l). This
textbook, entitled Clinical Hematology) was first
published in 1901 and predated Wintrobe's fanlous
textbook of the same name by 4-1 years. A second
edition appeared in 1905 and was used in the
teaching of medical students during their rotation
in the newly created Laboratory of Clinical
Medicine. This laboratory, first installed in the
Jefferson Medical College Annex building on
Tenth Street, was then considered one of the first
and most advanced developments in the use of a
laboratory for medical teaching. It was directed in
turn by Doctors Erwin D. F1Ulk, Henry Mohler,
and IIarold Jones, but it was under Dr. Jones'
leadership that it first became hematologically
oriented.

I

N THE

Early Hematology at Jefferson
Dr. Harold W. Jones (1891-1959), after graduation
from Jefferson in 1917, served as a Lieutenant in
the Army Medical Corp at Fort Oglethorpe. From
1919 to 1921 he was Chief Resident physician at
Jefferson (figure 10-2). He practiced for a while as
a general internist, but after being put in charge
of the Laboratory of Clinical Medicine his interest
turned to disorders of the blood. One of the main
functions of the course in Laboratory Medicine
then as now was to teach medical students how to
examine and observe blood, but he realized that
there was very little clinical or patll0physiologic
follow-up. He suggested to Dr. Thomas McCrae,
the Magee Professor of the Principles and Practice
of Medicine, that Jefferson should establish what
we now would designate as the Division of
Hematology. Specifically, he suggested the
development of three facilities: one for the
accurate study of patients with blood disorders
by specially trained technical and professional
personnel; one consisting of laboratories for tlle
long-term study of fundamental aspects of blood
diseases; and one for a facility to provide
transfusions of carefully matched blood.
The present Division of Hematology was an
outgrowth of these early ideas, but until 1939
no organizational facility could be established
because of lack of funds. Nevertheless, Dr. Jones
proceeded with independent and unfunded studies
of blood diseases and blood transfusions. He
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• Leandro M. Tocantins (1901-1963)

published widely and wrote a numb~r of t~xtbook
articles dealing with the problems of anemia, .
hemorrhagic disorders, and the direct a!ld II1dlreet
transfusion of blood. Jones was one of the
f<:lI.lIlders of the Jdkrson Society f()r Clinical
Investig:ltion :It his :llm<1 mater. Nationally, he
was known as <1n outstanding physICian :lnd
hematologist, was elected to kllowship in the
American College of Physicians, and was made a
member of the Association of American PhYSICIans
and the Interurban Club.
I

In his work and hematologic interests Jones was
supported by Dr. Leandto M. Tocantins (19011963), a young Brazilian-born phYSICIan who
graduated from Jefferson Medical College 111 the
Class of 1926 after a classic premedICal education
abroad and at Cornell University (Figure JO-3).
He interned at Chestnut Hill Hospital and
then practiced general medicine for three y~ars in
Cleveland, Ohio. Tocantins returned to Jefferson
and became a J. Ewing Mears Research Teaching
Fellow until 1936, after which he received a faculty
appointment. Dr. Tocantins early became involved
in the study of hemostasis and blood coagulatIon,
but his interests were, like those of Dr. Jones,
directed at all aspects of hematology. He
published widely on such diverse subjects as
anti-platelet serum, urine antl-thromboplastll1,
bone marrow infusions, lipid anticoagulants, and
abnormal hemoglobins. As a special student of
bleeding disorders, his name became linked to the
effect of inhibitors of blood coagulatIon and
especially the hypothesis that hemophilia is caused
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Harold W Joncs, M.D. (1891-1919).
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by such inhibitors. His work on blood platekts
resulted in the classic monograph Mammalian
Blood Platelets in Health and Disease) published in
1938, which exerted a major influence on
subsequent studies of this blood component?
Tocantins also spearheaded the field of
autoimmunity by infusing an anti-platelet serum
and producing thrombocytopenia. This study
led to attempts to treat both idiopathic
thrombocytopenic purpura and acquired hemolytic
anemia with macrophage blocking agents such as
radioactive gold.
These were years in which investigators
provided for their own livelihood through busy
medical practice and squeezed research into spare
hours and free weekends. The new Magee
Professor of Medicine, Dr. Hobart A. Reimann,
was keenly aware of that and hoped for a day
when investigators could be released from the
burden of full-time practice and devote a major
part of their time to scientific investigation within
their special fields. Dr. Reimann was also a strong
supporter of Dr. Jones' effort to develop a
Division of Hematology, but funds were needed
to fulfill these dreams. It was not until 1939, when
Mr. and Mrs. Thomas D. Cardeza became
interested in the project, that substantial baclung
was obtained for the development of a
research-oriented Division of Hematology.

Mr. Thomas Drake Martinez Cardeza (1875-1952)
was the last scion of the Drake fanlily, which came
to the United States from Leeds, England in 1828
(Figure 10-4). His ancestors Thomas Drake (18071890) and his brother moved to Philadelphia from
Ohio in 1837 and established a small woolen mill
in Manayunk. They began to manufacture jeans
under the trade name of "Kentucky Jeans." Their
business prospered with the establishment of

FIG. IO-'. Leandro M. Tocantins, M.D. (1901-196,).

FIG. 10-4-. Thomas Drake Martinez Cardeza (1875-1952).

The Cardeza Foundation
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additional mills near the present South Street
Bridge and at Twenty-first and Pine Streets. With
the heavy demand for woolens by the Union
Army, further expansion took place, and at the
end of the Civil War Thomas Drake retired a
wealthy man. He was highly respected in the
business community and was able to augment his
f()rtune with successful investments in real estate.
He held a number of trusteeships and was an
organizer and director of the old Fidelity Trust
Company, a position he held until his death in
[890. With his wik Matilda and seven children,
Mr. Drake lived the style of the very rich. In his
large estate in Germantown he had a small zoo,
with free-roaming elks and bison, and kennels for
Great Dane dogs. S:h.ily, six of his seven children
died at a young age, many from scarlet fever,
leaving Charlotte Drake ([854- [939) as the sole
heiress to his fortune.
In 1874, Charlotte married James Warburton
Martinez Cardeza, the grandson of Count Juan
Martmez Cardeza, a nobleman from La Coruna,
Spain. However, 'lher her only son Thomas was
born, she divorced and from then on devoted her
lit<: to her son ,1lld to the sports and pleasures of
the lc1sure cbss (figure 10-5). She and Thomas
circumna\'ig,1ted the globe on her steam
ocean-going y,1Chr, The Eleanor, with its crew of 39
and guest rooms tor 16 (Figure 10-6). As an ardent
and accomplished hunter she pursued big game in
India and Africd. She ,lIld Thomas maintained a
bunting lodge at Moose Head Lake in Maine, a
shooting establishment in Montana, and a huntmg
Schloss in Austria. She was also ,I patron of the
opera and or the Academy of Music, and was
a witty and beautiful lady of high society in
Philadclphl:l. In 1912, she and Thomas were on the
Tttamc together but both survived (Figure [0-7).
All kinds of rumors were circulated afterwards
about bow Tbomas had gotten into a lifeboat,
rumors that undoubtedly made hiS survival
ditlicult to enjoy.
From all accounts, it appears that CharlOtte ran
the family with a firm band. When Thomas
married Mary Racine (1880-1943), another
determined woman (Figure 10-8), he was caught

between two strong-willed ladies separated by
background and religion. Mary was born in
France and was a Roman Catholic. They were
married in secret, and the conversion of Thomas
to Catholicism was difficult for Charlotte to
accept. However, botb families lived in estates not
far apart in Germantown and together they
maintained the zoo and kennel established by
Thomas Drake.
After World War I, Mary developed a chronic
incapacitating illness, the nature of which is
unknowll, but it led her into a close personal and
professional relationship with Dr. Harold Jones at
Jefferson. He became a close friend of the family
and treated Mrs. Cardeza both at home and in
Jefferson hospital with a variety of medications,
including direct infusions of small amounts of
whole blood obtained from a donor at the
bedside. He talked to them about his dream of
establishing a transfusion and hematology research
center at Jefferson. When Charlotte Drake Cardeza
died in 1939, Thomas and Mary decided to
support the development of such a center in her
memory.

FIG. 10-1.

DtvlSZun of Hematology

Mrs. Charlotte Drake Cardeza (1854--1939).
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On December 14, 1939, at a memorable dinner
at the University Club, attended by Mr. Cardeza
and many department heads, Dr. Jones toasted the
establishment of a Hematology Division in the
Department of Medicine (Figure 10-9), to be
nanled The Charlotte Drake Cardeza Fowldation
for the Study of Diseases of the Blood and Allied
Conditions. After two years of legal and academic
discussions between Mr. J. Harry Wagner, legal
counsel for the Cardezas, and Mr. Robert P.
Hooper, President of the Board of Trustees of
Jefferson, the Charlotte Drake Cardeza Foundation
was formally incorporated on October 17, 1941, to
be directed by Dr. Harold Jones, as the first
Thomas Drake Martinez Cardeza Professor of
Clinical Medicine and Hematology in the
Department of Medicine (Figure 10-10). Jones was
allotted a teaching service in the Department of
Medicine, plus adult and pediatric hematology

FIG. 10-0.

beds in the Hospital. Staff members for the
Division of Hematology and a number of research
and teaching Charlotte Drake Cardeza Fellows
were recruited. The Division was to conduct and
operate a Transfusion-Plasma Unit and a Biologic
Photographic Unit, activities to be supported by
an annual grant from the Cardezas of $50,000 for
not less than ten years, $7,500 of which could be
used tor the salary of the Director of the Division
of Hematology.
Although the Charlotte Drake Cardeza

Charlotte aod Thomas Drake Cardeza on board The Eleanor.
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Foundation served as the Division of Hematology
of the Department of Medicine, the Director
reported to a Cardeza Foundation Advisory
Committee of the faculty appointed by the Board
of Trustees, rather than to the Chairman of the
Department of Medicine. The Committee in turn
reported to the Board of Trustees. Subsequent
cJunges in the line of command provided tor two
channels, one academic, via the Chairman of the
Department of Medicine, and one fiscal, via a
Cardeza Foundation Faculty Advisory Committee
to a Joint Advisory Committee comprised of
appropriate individuals representing the Board of
Trustees, administration, faculty, and the Cardeza
Trust.
ML Cardcza was the first Chairman of the JOll1t
Advisory Committee, and until 1947 he had almost

0:::!.!_lH:'~' II"
l>t ":;I:··•• J...u:ll",:.I(~;.x~,,, .. ~(....

?ll,

daily administrative contacts with Dr. Jones. At
that point, he requested that Jefferson Medical
College take over supervision of activities of the
Foundation and changed the annual allotment
of $50,000 to a corresponding amount derived
from a Trust deposited at the Fidelity Bank.
Mr. Horace Liversidge became Chairman, and
Mr. Percival Foerderer and Mr. J. Harry Wagner
were two of the more active committee members.
With the additional support of a legacy of about
$100,000 from the Kress brothers, considerable
research was carried out in laboratories spread
throughout the College.
rn two small laboratories in the College
Building and one in Room 247 in the Thompson
Annex, Dr. Franklin A. Miller (Figure IO-II), who
had been recruited as Assistant Director, and
Dr. Leandro Tocantins, Co-Assistant Director, had
for that period a great opportunity to pursue their
research interest almost full-time. Dr. Miller's
interest was in the pathogenesis of malignant
lymphomas and leukemias. He succeeded in
isolating from the urine of patients with these
illnesses sever;}] substances that when injected into
guinea pigs would alter cellular proliferation.

l",,',~

WHITE STAR LINE

FIG. 10-7. Cabin door hardware and receipts of the
Cardeza passage on the Titanic.

FIG. 10-8. Mary Racine (1880-1943).
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Dr. Daniel Turner (Figure 10-12), an organic
chemist, characterized these substances, and in
many papers they hypothesized regarding their
possible pathogenetic relationship to malignancy.
Dr. Tocantins continued his work on platelets and
the coagulation inhibitor found in some patients
with hemophilia, and with Dr. Robert Carroll
(Jefferson, 1952) and Dr. Ruth Holburn (Figure
10-13) he established a Hemophilia Clinic.
Dr. Jones was primarily involved in patient
management centered around a clinic in the Curtis
Building designated the Blood, Spleen, and
Bone Marrow Clinic. With Dr. Lowell A. Erf,
Jones also established a Blood Bank in a small
building on Eleventh Street and became deeply
involved in the processing and administration of
plasma.
In 1952, Mr. Cardeza died and left his estate for
the support of The Charlotte Drake Cardeza
Foundation. Mter some years of intense legal
wrangling, his mansion in Germantown was

PRoCEEDINCS OF THE DINNER

HELD ON DECEMBER FOURTEENTIf.

1939

TO CELEBRATE

THE ESTASUSHMENT OF THE

CHARLOnE ORAlE CABDEZA FOUNDATION
roa THE STUDY OF

DISEASES OF THE BUDD
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~
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• The Sansom Street Center
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hG. 10-9. Dinner proceedings at the establishment of
Charlotte Drake Cardeza Foundation.
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bequeathed to the Archdiocese of Philadelphia,
and his fortune, about $3 million, was used to
establish a trust for the Foundation with
Mr. Wagner and the Fidelity Bank as co-trustees.
This input of funds permitted the recruitment of
more staff members. When Dr. Tocantins became
the new vigorous Director in 1954-, he spearheaded
nlrther expansion. Dr. Tocantins and Dr. Farid 1.
Haurani (Figure 10-14-) began studies on bone
marrow transplantation. Mter both exciting and
painful experiences they learned that although
autotransplantation was possible, still unknown
immunologic barriers prevented successful
heterotransplantation. 3 With the help of
Dr. Louis A. Kazal (Figure 10-15), Dr. Daniel
Turner, and Dr. Melvin J. Silver (Figure 10-16),
Dr. Tocantins continued his quest for the
identification of the elusive inhibitor that he
believed characterized hemophilia.4- That quest was
actually not finished until Dr. Sandor S. Shapiro
(Figure 10-17), after the death of Dr. Tocantins,
identified the inhibitor as a Factor VIn antibody
that develops in about ten to 15 percent of treated
patients with hemophilia.'
In [959 Dr. Allan J. Erslev was recruited from
the Thorndike Memorial Laboratory at Harvard as
Associate Director. He pursued his work on
erythropoietin, a renal hormone he had discovered
earlier. This hormone controls the rate of red cell
production and plays a major role in recovery
from blood loss and in adaptation to high
altitudes. D

The trust income was, according to Mr. Wagner,
restricted to support personnel and provide
supplies and equipment and could not be used for
renovation. Fortunately, a new chairman of the
Joint Advisory Committee, Mr. J. I Ioward Pew,
President of Sun Oil Company, saw the need for
providing a separate building for the Foundation,
and through his generosity a three-storied
property on 1015 Sansom Street was purchased and
completely renovated (figure 10-18). In [960, the

Thomas JejJerson University

Foundation moved in and tor the first time
became a coherent unit, permitting easy academic
and personal interaction among its members. The
move was followed by an expansion in personnel
and activities, an expansion greatly enhanced by
the new anilabiliry of federal research funds. In a
few years, tCderal grant support actually matched
and L:Xceeded trust income. The new Cardeza
quarters housed the Blood Donor Center, a
photographic unit, and laboratories and oftices
for a professional staff that had increased to
include 15 M.D.'s and Ph.D.'s, five to ten

FIG. 10-10.

Harold

W

JOIles,

American and foreign clinical and Research
Fellows, and a nonprofessional staff of about 60
technicians, secretaries, and maintenance personnel.
Academically, the Foundation was primarily the
Division of Hematology in the Department of
Medicine, bur it also served as the Division of
Hematology in the Departments of Pediatrics,
Physiology, and Pharmacology. It was responsible
tor the teaching of hematology to students and
house staft~ and clinically its members provided
consultations and care for hematologic patients in
the Jefferson Medical College Hospital.
In 1963, after Dr. Tocantins' sudden death,
Dr. Allan J. Erslcv (Figure 10-19), a native of
Denmark (born in 1919), became Director. He
continued the recruitment of new investigators
and expansion of federal funding. Dr. Sandor
Shapiro (Figure IO-17), the first senior recruit, was
trained at Harvard and Massachusetts Institute of
Technology; after arrival at Cardeza he established

M.D. and his Cardeza StatT.
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a Thrombosis and Hemorrhagic Disease Section
and a state-supported Hemophilia Center.
With Drs. Melvin Silver, Louis Kazal, Jose
Martinez (Figure 10-20), and J. Bryan Smith
(Figure 10-16), Shapiro spearheaded research in
coagulation-factor kinetics, the immunologic
basis for some coagulation disorders, and the
biochemical processes involved in platelet
aggregation and release action. 7 - II Dr. Edward
Burka, Dr. Elias Schwartz, Director of the
Division of Pediatric Hematology, and Miss Jean
Atwater (Figure IO-2T), Head of Cardeza
Laboratories, studied normal and abnormal
hemoglobins and identified the defects responsible
for several hemoglobinopathies and
thalassemias. 12• 13 Their laboratories served as a

FIG. 1O-I2.

FIG.

10-11.

Franklin R. Miller, M.D.

Da.niel Turner, Ph.D.

FIG. 10-13. Ruth Holburn, Ph.D.
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nationally recognlZ<.::d referral center for abnormal
hemoglobins. Dr. Burka ,llso established a
state-supported Sickle Cell Center ,lI1d became
Blood Bank Director. These positions were 1,lter
taken by Dr. S,1I1llr K. 13,llldS, with the ,Issistance
of Dr. Stephen P. Hauptn1.1n t()r tissue typing ,lI1d
Dr. Scott Murphy (Figure 10-22) t()r blood
fractlon,1tion. Dr. 13,II].ls' Interest W,IS directed
nuinly ,1t the red cell membr;me with Its extel'lLII
antIgenic slte~ ,1I1d intern,ll structur,l] skelcton,'+
while Dr. Hauptm,1I1 studied the sal11(.' membr,1I1e
structures on lymphocytes." Dr. Murph)'\ prImary
interest was platelets, ,lI1d he established stor.lge
condition,., t()r pl'ltekts that etfcctlvely incre,l.'>ed
their shelf lite from hours to the present
seven d,l)''', II, Dr. Susan TrJvis, who t()llowed
Dr. Schwan7 ,\,,> Director of Pedi,ltric Hem,tto!ogy

Mr Olin Milkr (technician to Louis 1<"17;,11 t()r
LOlli' A. K,1Z,11, Ph.D., and Sandor
Sh,lf'll'O. M.D.
FIG, 10-tl

,0

FIG. 10-1+

F,lrId I Haur;1nl, M D

\C,1I").

FIG. fa-lb. Meh'lI1
Smith, Ph.D

J

Silver, D.5e., and J Bryan

was primarily involved in unraveling red cell
enzyme function. 17 Dr. Haurani's interest centered
on iron and BI2 metabolism. He directed dle
Jefferson branch of the National Cooperative
Acute Leukemia Group B (ALGB). Dr. ErsJev
continued his research in erythropoietin with
Dr. Thomas Gabuzda, Dr. Ruth Silver, and
Dr. Lewis KazaJ. Later, Dr. Jaime Caro joined his
team and provided fi.lrther information about the
renal biogenesis and bone marrow action of this
hormone. Is They also established a research and
referral center for erythropoietin bioassays and for
the diagnosis of polycythemia vera, secondary
polycythemia, and the anemia of chronic renal
disease.
Concomitantly with these research activities, all
clinical members of the Cardeza Foundation were
members of dle Cardeza Associates of Clinical
Hematology and shared in consultations at the
Thomas Jefferson University Hospital. With the
competent support of some outstanding nurses,
(Marian Ramp and Kay Houser are excellent
examples), they provided in- and outpatient
management of patients with hematologic

FIG. 10-18.

FIG.

10-]7.

Sandor S. Shapiro, M.D

The Cardeza Foundation at

Fw. IO-J9· Allan
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J. Erslev, M.D.

lOIS

(1919-).

Sansom Street.

disorders. Assisted by the more clinically oriented
faculty members, Drs. John Hodges and Edward
McGehee, they ,1lso taught hematology to
Jefferson students and house staff and provided
clinical and research instruction to Fellows
supported by two National Institutes of Health
Training Grants.
Numerous reviews and textbook articles
resulted. Dr. Erslev became coeditor of a major
textbook, Hematology, and, with Dr. Gabuzda,
coauthor of a small paperback Pathvphysiology of
Blood. 20 Both books have gone through three
editions.
1<)

FIG. 10-21.

Jean Atwater.

In 1975, the Cardeza building had to make room
for the new Thomas Jefferson University Hospital.
The foundation moved into 1,600 square feet of a
completely renovated laboratory and office space
on the seventh, eighth, and ninth floors of the

fIG. 10-20_

Jose M:lrtinez, M.D.

hG.

10-22.
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Scott Murphy, M.D.

Curtis Building (Figure 10-23). The Cardeza Blood
Donor Center and Tissue Typing Center as well as
the Sickle Center moved into the first floor and
the Cardeza Hcrnophilia Unit into the second
floor of the old hospital, and the outpatient
facilities were located eventually on the fourth
floor of the New Hospital. The move into new
laboratories symbolized the move in research
£i'om the days of traditional morphologic and
pathophysiologic studies to the current phase of
molecular biology. Studies became characterized
by monoclonal antibodies, restriction enzyme
analysis, radioimmune assays, membrane receptor
analysis, cell sorting, and gene cloning. Young
investigators such as Drs. Perumal Thiagarajan,
Carol lngerman- Wojenski, Patricia Catalano,
Iftekhar Alam, and Jaime Caro adopted these new
techOlques and turned research efforts at Cardeza
in that direction. Although the funding never
seemed to match expenditures, the annual Cardeza
budget was maintained in precarious balance by

the competent juggling of the administrative
assistants, Bella Sigal and Helen Gilliam. In 19841985, the budget reached about $3.5 million, with
$2.3 miIJion provided from federal grants and
contracts.
In 1985 Dr. Erslev stepped down as Director
of the Division but remained at Jefterson to
continue his research on red cell diseases. He was
immediately named Distinguished Professor of
Medicine, the first in the Department of Medicine
to be so honored. Previous awards included a
Guggenheim Fellowship, presentation of his
portrait by the Class of 1972, and the first

FIG. ro'23. Hematology conference room and Leandro M. Tocantms LIbrary on the ninth floor of [he Cunis Building
([975).
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6. Erslev, A.J., "Humoral Regulation of Red Blood Cell
Production," Blood 8:34-9-357, 1953.
7. Shapiro, 5.5., and Martinez, j., "Human l'rothromblll
Metabolism in Normal Man and in Hypercoagulable
Subjects," J. Gin. Invest. 4-8:1292-1298, 1969·
8. Smith, I.B., and Silver, M.J., "Prostaglandin Synthesis by
Platelets and its Biologic Significance," Platelets in BiololIY and
Pathology. j. Gordon, ed. New York: Elsevier, 1976, pp. 3313.1 2 .

William B. Castle Lectureship at Boston
University. He remained prominent in many of
the important clinical and research societies related
to his field both here and abroad.
The Division may look back with pride to its
contributions to the understanding and treatment
of diseases of the blood and look forward under
the new kJ.dership of Dr. Sandor Shapiro to the
challenge of a future in hematologic molecular
biology.
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